President Donald Trump has chosen Dr. Heidi Overton, deputy director of the White House Domestic Policy Council, to serve as the next commissioner of the Food and Drug Administration, according to reporting first published by Bloomberg on Tuesday and since matched by multiple outlets citing people familiar with the decision. The White House, the FDA, and Overton had not commented publicly as of this writing, and no formal nomination has been transmitted to the Senate.
The timing matters more than the personnel news alone. Whoever takes the job inherits an agency that has lost more than 3,000 staff over the past year, including division heads, according to Reuters, while simultaneously running several active foodborne illness investigations that have produced hundreds of confirmed cases and a recall list touching most major American grocery chains.
For households, that combination is the practical story. The FDA is the agency that decides when a recall is announced, how quickly a contaminated ingredient is traced, and whether the public hears about a problem before or after the product reaches a refrigerator. Leadership stability affects how fast those decisions get made.
The Agency She Would Inherit
The FDA has been run by an acting commissioner, Kyle Diamantas, since May, when Dr. Marty Makary resigned 13 months into the job after clashing with White House and health advisers. Reuters reported that Makary drew criticism over his handling of the return of flavored vapes to the market, a stalled abortion pill review, and public disagreements with drugmakers including Replimune, Sarepta, and Moderna over product reviews. Since Diamantas took over, the agency has reversed course or reopened regulatory paths for several rare disease therapies.
Other senior FDA positions remain without permanent leadership. A senior administration official told Axios that more appointments are likely to follow this one closely.
Meanwhile, the food safety workload has not paused. The agency's jalapeno outbreak investigation has been linked to 345 Salmonella Javiana illnesses and 36 hospitalizations across 27 states, traced to peppers grown in Sinaloa, Mexico, and distributed by Coast Citrus Distributors, with downstream recalls reaching Kroger, Target, Trader Joe's, Walmart, Whole Foods, and other chains. A separate shell egg investigation linked to eggs recalled by Midwest Poultry Services, produced on Texas farms, has been associated with 98 Salmonella Enteritidis illnesses and 26 hospitalizations across 17 states.
The Background She Brings to the Job
Overton is a physician. She earned her medical degree at the University of New Mexico School of Medicine, trained in general surgery at Johns Hopkins, and completed a doctorate in clinical investigation at the Johns Hopkins Bloomberg School of Public Health. She is board-certified in public health and general preventive medicine, and served as a White House Fellow during the first Trump administration.
Before joining the White House in January of last year, she was chief policy officer and vice chair of the Center for a Healthy America at the America First Policy Institute, a conservative think tank. Reuters reported that she was among three candidates the administration focused on, alongside the oncologist Dr. Jeffrey Vacirca and Pentagon health official Stephen Ferrara.
The reaction has been mixed rather than uniform. STAT reported that she has, at times, frustrated leaders of the Make America Healthy Again movement, indicating that her policy positions are not fully predictable from her affiliations. Industry analysts quoted by Axios were more skeptical, questioning her management experience and warning that departures among career staff could continue. None of that is a verdict on how she would run the agency, and she has not laid out an agenda publicly.
The Confirmation Fight That Would Follow
Nothing about this appointment is settled. A nomination would go before the Senate Health Committee, which has recently demonstrated it will not simply wave health nominees through. The Senate narrowly confirmed the administration's pick to lead the CDC, Dr. Erica Schwartz, earlier this month, but only after Republican Sen. Bill Cassidy delayed the process over concerns about the administration's vaccine policies.
Overton was among the senior officials standing behind the president when he signed an executive order calling for changes to the childhood vaccine schedule, CNN reported. The order drew criticism from Cassidy and from much of the public health establishment, and that association is likely to feature in her hearing.
Readers should treat the vacancy itself as a confirmed fact and the rest as pending. No nomination has been formally submitted, no hearing has been scheduled, and how Overton would approach food safety enforcement, drug review timelines, or recall communication has not been stated publicly.
The Household Effect of a Leadership Gap
The connection between a commissioner's confirmation calendar and a family's kitchen is not abstract, though it is indirect. Recall decisions, outbreak advisories, and enforcement classifications are made by career staff, and those functions continue during a leadership transition. What a prolonged vacancy affects is the pace of policy decisions above that level, including how the agency allocates inspection resources and how quickly it resolves questions that require a commissioner's sign-off.
The most useful thing a household can do is not to track confirmations, but to track recalls. Anyone who shops for fresh produce, prepared refrigerated foods, or shell eggs should check the FDA recall page periodically through the end of the summer, because several of the current investigations remain open with distribution lists that have expanded more than once.
People at higher risk from Salmonella—children under five, adults over 65, pregnant people, and anyone immunocompromised—have more reason to check than most. Symptoms typically begin six hours to six days after exposure and include diarrhea, fever, and stomach cramps lasting four to seven days. A fever above 102 degrees, bloody stool, vomiting that prevents keeping fluids down, or diarrhea lasting more than three days warrants a call to a clinician.
The next confirmed step is a formal nomination and a Senate Health Committee hearing date. MedicalDaily will report on both and on any changes to how the agency handles open outbreak investigations in the meantime.
Key Questions Answered
Has Overton been nominated? Not formally. Multiple outlets report that the president has chosen her, based on people familiar with the decision. A nomination must still be submitted to the Senate.
Who is running the FDA now? Kyle Diamantas has served as acting commissioner since May, when Dr. Marty Makary resigned after 13 months in the role.
What is her medical background? She holds a medical degree from the University of New Mexico, trained in general surgery at Johns Hopkins, and earned a doctorate in clinical investigation from the Johns Hopkins Bloomberg School of Public Health. She is board-certified in public health and preventive medicine.
Would she face a difficult confirmation? Possibly. The Senate Health Committee recently delayed the CDC director's confirmation over vaccine policy concerns, and Overton was present for the signing of an executive order on the childhood vaccine schedule.
Does this affect current recalls? Not directly. Recall classifications and outbreak advisories are handled by career staff and continue during a leadership transition.
Which outbreaks are open right now? A multistate Salmonella Javiana outbreak linked to jalapenos, with 345 illnesses in 27 states, and a Salmonella Enteritidis outbreak linked to recalled shell eggs, with 98 illnesses in 17 states.
What should shoppers do while this plays out? Check the FDA recall page periodically, particularly if you buy fresh produce, refrigerated prepared foods, or shell eggs, since several investigations remain open and distribution lists have expanded more than once.
